The FGFR2 gene helps guide how cells grow and how the skull, face, limbs, and other tissues develop before and after birth. This gene plays an important role in signals between cells, which tell growing tissues when to divide and mature. When a harmful variant changes this signaling, some bones may fuse too early and certain body parts may develop differently. Certain FGFR2 variants are linked to inherited conditions such as Apert syndrome and Crouzon syndrome, and some acquired variants are found in cancers.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions for making molecules or guiding processes in the body. Some genes carry the directions for producing proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To go into this topic in greater depth, you can find more in the LearnHub.
Overview
FGFR2Gene function
What if the gene works
The FGFR2 gene helps cells receive growth signals, especially during early development. It supports the formation of bones, skin, and other tissues and helps guide normal cell growth and repair.
Risk
What if the gene does not work
Variants in the FGFR2 gene most often affect skull and bone growth, causing craniosynostosis syndromes such as Apert, Crouzon, and Pfeiffer. Effects can range from milder facial or dental differences to earlier, extensive skull fusion with limb or airway problems.
Treatment
What does that mean for your treatment
No FGFR2-specific treatment or drug selection approach is currently established for inherited pathogenic or loss-of-function variants in the FGFR2 gene. Separately, FGFR2 is an established drug target in some cancers when tumors carry specific activating FGFR2 fusions or rearrangements, which does not apply to most inherited FGFR2 variants.
Conditions associated with FGFR2
Gene function
What if the gene works
Your cells use the FGFR2 gene to receive growth messages from nearby tissues. These messages help guide how cells grow, mature, and arrange themselves, especially during early development. This supports normal formation of bones, skin, and other body structures.
The FGFR2 gene helps cells detect nearby growth signals and pass that message inward. This lets cells respond at the right time and in the right place.
One of its main roles is to help cells know when to grow, divide, or settle into a steadier pace. This supports controlled tissue building during development and normal tissue upkeep later on.
Signals linked to the FGFR2 gene help developing cells mature into the right type for their tissue. This is important for building body structures with the correct shape and job.
During early growth, the FGFR2 gene helps guide bone growth and the formation of the skull, face, limbs, and skin. It helps nearby cells coordinate their actions so these tissues develop in an organized pattern.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the FGFR2 gene change the receptor’s shape or processing, so cells receive growth signals at the wrong time, in the wrong place, or too strongly. Some variants make signaling overly active or change which partner signals can bind, while others reduce receptor stability or activity. This range helps explain how variants in the FGFR2 gene affect protein function: milder changes may shift signaling less, while more disruptive variants can be linked to earlier or more pronounced features in FGFR2-related conditions.
How variants are linked to conditions
Pathogenic variants in the FGFR2 gene cause several inherited craniosynostosis conditions, including Apert syndrome, Crouzon syndrome, Pfeiffer syndrome, and some related syndromes in which skull bones fuse earlier than usual. Other FGFR2 gene variants and breast cancer risk have also been linked in population studies, where some common changes are associated with a small increase in risk rather than a diagnosis. Effects vary by the specific variant.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common throughout the general population. Most variants do not have a direct impact on health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some cases, though, one well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For inherited FGFR2-related conditions, the main risk usually comes from the gene change itself rather than lifestyle or everyday exposures. Some new FGFR2 changes happen by chance before birth, and older paternal age has been linked with a higher chance of these new changes.
Inheritance of FGFR2 variants
Most FGFR2-related conditions are inherited in an autosomal dominant pattern, which means one altered copy of the FGFR2 gene can be enough to cause the condition. If a parent carries a disease-causing variant, each child has a 50% chance of inheriting it. Inheritance of FGFR2 gene variants can also begin with a new, de novo variant, meaning the change appears for the first time in the child and was not inherited from either parent. A parent of any sex can pass an FGFR2 variant to a son or a daughter.
What does my FGFR2 result mean for my family?
Many health conditions linked to the FGFR2 gene follow a dominant family pattern, so a parent, child, brother, or sister may also carry the same gene change. This can matter even when signs are milder in one family member than another. Some FGFR2 changes happen for the first time in a child, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the FGFR2 gene usually uses a blood or saliva sample. A lab reads the DNA sequence of the gene to look for changes, and FGFR2 genetic testing can help confirm whether a known variant is present in a person with signs of a condition linked to this gene.
When should I consider getting a genetic test?
Testing for the FGFR2 gene may be worth discussing if a baby or child has early fusion of the skull bones, an unusual head shape, prominent eyes, or hand and foot differences, or if these features run in the family. It can also help when a parent or close relative has a known change in FGFR2.
A genetic result is only one part of your health story
A genetic result can provide helpful insight, but how much it reveals depends on the condition and the kind of variant involved. Age, lifestyle, environment, and medical history all play a role in how the body functions over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Differences in how the body breaks down, transports, or responds to a drug are common and can influence both benefit and sensitivity to treatment.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences affect how people respond to medications. By studying the links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. To learn more about this topic, you can explore the LearnHub.
Drugs influenced by the FGFR2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in routine medication response, so general questions about medicines or side effects are best discussed with your doctor. In cancer care, FGFR2 changes found in tumor cells can sometimes help guide the use of certain targeted treatments, but that is different from inherited drug-response testing.
History
Inherited patterns were noticed long before the FGFR2 gene was identified. In the 1990s, researchers linked changes in the FGFR2 gene to several craniosynostosis conditions, including Crouzon syndrome and Apert syndrome, helping explain why certain skull and facial features can run in families. This was an important step because earlier diagnosis had relied mainly on physical features and X rays. Building on this early work, scientists uncovered more about the FGFR2 gene by connecting specific variants with somewhat different clinical patterns. These findings helped move care from description alone toward genetic confirmation. Over time, the history of the FGFR2 gene became part of the broader story of how doctors learned to match inherited conditions with their genetic cause.